Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials

S D Heys, L G Walker, I Smith, O Eremin, S D Heys, L G Walker, I Smith, O Eremin

Abstract

Objective: To conduct a meta-analysis of 11 randomized controlled trials comparing enteral nutritional support supplemented with key nutrients versus standard enteral nutritional support to determine effects on morbidity and mortality rates and hospital stay.

Background data: Recent studies have shown that malnutrition occurs in up to 30% of patients undergoing gastrointestinal surgery, resulting in an increased risk of postoperative complications and death. With the realization that key nutrients can modulate inflammatory, metabolic, and immune processes, enteral nutritional regimens (supplemented with large amounts of key nutrients) have been developed for clinical use.

Methods: Eleven prospective, randomized controlled trials evaluating 1009 patients treated with combinations of key nutrients (Impact, Immun-Aid) were evaluated. Outcome measures examined were the incidences of pneumonia, infectious complications, and death, and length of hospital stay. Meta-analyses were undertaken to obtain the odds ratio and 95% confidence interval for incidences of infectious complications, pneumonia, and death, and the weighted mean difference and 95% confidence interval for length of hospital stay.

Results: The provision of nutritional support supplemented with key nutrients to patients with critical illness resulted in a decrease in infectious complications when compared with patients receiving standard nutritional support and a significant reduction in overall hospital stay. Similar results were documented in patients with gastrointestinal cancer. However, there were no differences between patient groups for either pneumonia or death.

Conclusions: This meta-analysis has demonstrated that nutritional support supplemented with key nutrients results in a significant reduction in the risk of developing infectious complications and reduces the overall hospital stay in patients with critical illness and in patients with gastrointestinal cancer. However, there is no effect on death. These data have important implications for the management of such patients.

References

    1. N Engl J Med. 1991 Aug 22;325(8):525-32
    1. Lancet. 1989 Feb 4;1(8632):231-3
    1. Med Care. 1991 Mar;29(3):251-71
    1. Ann Intern Med. 1992 May 15;116(10):821-8
    1. Surgery. 1990 Aug;108(2):331-6; discussion 336-7
    1. Clin Sci (Lond). 1992 Apr;82(4):413-7
    1. N Engl J Med. 1985 Sep 12;313(11):660-6
    1. JPEN J Parenter Enteral Nutr. 1997 May-Jun;21(3):133-56
    1. Ann Surg. 1994 Aug;220(2):212-21
    1. Ann Surg. 1995 Apr;221(4):327-38
    1. J Trauma. 1994 Oct;37(4):607-15
    1. J Trauma. 1997 May;42(5):933-40; discussion 940-1
    1. Crit Care Med. 1995 Apr;23(4):652-9
    1. Am J Infect Control. 1988 Jun;16(3):128-40
    1. Eur J Surg Oncol. 1995 Apr;21(2):224-7
    1. J Trauma. 1997 May;42(5):793-800; discussion 800-2
    1. Crit Care Med. 1995 Mar;23(3):436-49
    1. Clin Sci (Lond). 1994 Dec;87(6):711-7
    1. Int J Technol Assess Health Care. 1990;6(1):5-30
    1. Immunology. 1997 Oct;92(2):166-72
    1. Cancer Immunol Immunother. 1994 Oct;39(4):217-22
    1. Crit Care Med. 1997 Sep;25(9):1489-96
    1. JAMA. 1996 Aug 28;276(8):637-9
    1. Int J Oncol. 1998 Jan;12(1):221-5
    1. Br J Surg. 1996 May;83(5):608-19
    1. Clin Pharmacol Ther. 1995 Dec;58(6):605-16
    1. Crit Care Med. 1998 Jan;26(1):24-30
    1. Surgery. 1994 Feb;115(2):205-12
    1. Surgery. 1995 Sep;118(3):531-8
    1. Infusionsther Transfusionsmed. 1995 Oct;22(5):280-4
    1. J Natl Cancer Inst. 1959 Apr;22(4):719-48
    1. J Nutr. 1991 Apr;121(4):547-55
    1. J Clin Epidemiol. 1992 Mar;45(3):255-65
    1. Br J Surg. 1992 Jul;79(7):614-23
    1. Nutrition. 1990 Jan-Feb;6(1):84-7; discussion 96-8
    1. Nutrition. 1996 Jun;12(6):423-9
    1. Ann Surg. 1986 Jul;204(1):1-8
    1. Br J Surg. 1983 Jan;70(1):29-31
    1. Surgery. 1992 Jul;112(1):56-67
    1. Ann Surg. 1996 Oct;224(4):531-40; discussion 540-3

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit